ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PPIX Prophotonix Limited

8.75
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Prophotonix Limited LSE:PPIX London Ordinary Share COM SHS $0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.75 8.50 9.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Prophotonix Share Discussion Threads

Showing 351 to 374 of 550 messages
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
DateSubjectAuthorDiscuss
11/10/2019
08:26
Buywell3. There is no axe to grind. I�m just making people aware of your devious and unsavoury tactics to dupe others for your own financial benefit. There are plenty of people who know you for who you are and the damage you try to do on other companies threads.
You have obviously lost money yesterday and this is now an attempt at gaining some back.
If you Slate other peoples investments then be prepared for the same treatment.

jamesrs1
11/10/2019
08:25
POST REMOVED
buywell3
11/10/2019
08:24
Nothing in the PR yesterday saying it�s a new customer. In fact is likely to be a current one if the have been working with them for four years.

They need a capital raise.

Turnover is likely to be less than 15m this year.

But the main reason I�d never hold this, in the good years they just pay themselves more. Nothing in it for shareholders.

dr biotech
11/10/2019
08:13
POST REMOVED
buywell3
10/10/2019
13:14
Buywell3 = lies and deception. Whenever you see his name. Also goes under the name of Buywell 1,2,3,. Investors beware.
jamesrs1
10/10/2019
13:03
Wonder how much new capital they�ll need? If they raise 1m at 0.5p anyone who holds is going to be ridiculously diluted.

Seems the market has already seen through the pump. I expect a few more attempts at fluffing the share price before the placing.

dr biotech
10/10/2019
12:33
Losik compensation 2018 $325K so cost of shares bought high by UK standards not such a hole in his earnings.
pugugly
10/10/2019
11:52
POST REMOVED
buywell3
10/10/2019
11:42
POST REMOVED
buywell3
10/10/2019
09:41
Don�t believe somebody who is trying to make a quick buck by encouraging others to buy. It�s a clear ramp to the hilt then sell at a profit.
jamesrs1
10/10/2019
09:24
POST REMOVED
buywell3
10/10/2019
09:22
Buywell3 is openly slating this company on another thread advising others to take advantage of the rise before it returns to 1.5p.
jamesrs1
10/10/2019
09:19
POST REMOVED
buywell3
10/10/2019
09:09
Lots of red flags in that statement. Company hasn�t got enough cash to last five years - being a non regulatory RNS, smells of pump and dump to me.

Your 12p ramp is down what 85% instead of 90? And then you think we�ve missed out. LOL

dr biotech
10/10/2019
09:00
POST REMOVED
buywell3
10/10/2019
08:59
An extra $1m revenue per year you say?

In the last H1 results they lost $1.6m of revenue in the last six months alone.

rcturner2
10/10/2019
08:57
Do I smell a ramp prior to a new placing?????
pugugly
10/10/2019
08:56
POST REMOVED
buywell3
10/10/2019
08:52
POST REMOVED
buywell3
10/10/2019
08:39
Psml. �Missed the boat�. That particular boat being the titanic when Buywell was ramping this at 12p.


Non binding agreement. Anyone else notice this was a PR announcement not an RNS. Can pretty much say what you like in those.

dr biotech
10/10/2019
08:25
Shame you can't buys these shares unless you sign the US tax rules
amrishbhim
10/10/2019
08:10
POST REMOVED
buywell3
10/10/2019
08:01
POST REMOVED
buywell3
10/10/2019
08:00
From recent results

"As noted above, we are now forecasting revenues in the second half will broadly approximate those achieved in the first half. Whilst we expect to see the financial benefit of the cost savings initiatives enacted in the first half, the Board believes the Company will continue to be loss making and is committed to strengthening the Group's balance sheet. The Board is therefore reviewing all funding and strategic options available, both to ensure the short-term working capital needs of the Company continue to be met, as well as maximizing shareholder value over the longer term.

cottoner
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older

Your Recent History

Delayed Upgrade Clock